/
Eur J Heart Fail
A pilot study of chronic, low-dose epoetin-β following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure
- M.W. Bergmann
- S. Haufe
- F. von Knobelsdorff-Brenkenhoff
- H. Mehling
- R. Wassmuth
- I. Muench
- A. Busjahn
- J. Schulz-Menger
- J. Jordan
- F.C. Luft
- R. Dietz